MedTrace Logo

Early Detection of Cardiac Amyloidosis

NCT05010980 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2022-10-31

No results posted yet for this study

Summary

Due to a lack of therapeutic options, the diagnosis of cardiac (wt)-ATTR amyloidosis was for a long time overshadowed by other diseases and therefore was or still is often diagnosed with considerable delay.

The aim of the study is to estimate the prevalence of cardiac amyloidosis among patients with mild-to-moderate aortic valve stenosis (AS).

Besides that a screening algorithm based on echocardiographic parameters will be developed, to facilitate the early detection of cardiac amyloidosis.

Conditions

  • Amyloidosis
  • Aortic Valve Stenosis

Interventions

OTHER

CMR

clinical indication

OTHER

scintigraphy

clinical indication

Sponsors & Collaborators

  • Heinrich-Heine University, Duesseldorf

    lead OTHER

Principal Investigators

  • Ralf Westenfeld, MD · Division. of Cardiology, Pulmonary Disease and Vascular Medicine

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-01
Primary Completion
2023-09-30
Completion
2023-09-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05010980 on ClinicalTrials.gov